|
1
|
Volkmar M, Dedeurwaerder S, Cunha DA, et
al: DNA methylation profiling identifies epigenetic dysregulation
in pancreatic islets from type 2 diabetic patients. EMBO J.
31:1405–1426. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Omori S, Tanaka Y, Takahashi A, et al:
Association of CDKAL1, IGF2BP2, CDKN2A/B, HHEX, SLC30A8, and KCNJ11
with susceptibility to type 2 diabetes in a Japanese population.
Diabetes. 57:791–795. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gu T, Horová E, Möllsten A, et al: IGF2BP2
and IGF2 genetic effects in diabetes and diabetic nephropathy. J
Diabetes Complications. 26:393–398. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kwak SH, Kim SH, Cho YM, et al: A
genome-wide association study of gestational diabetes mellitus in
Korean women. Diabetes. 61:531–541. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Grarup N, Rose CS, Andersson EA, et al:
Studies of association of variants near the HHEX, CDKN2A/B, and
IGF2BP2 genes with type 2 diabetes and impaired insulin release in
10,705 Danish subjects: validation and extension of genome-wide
association studies. Diabetes. 56:3105–3111. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jia H, Yu L, Jiang Z and Ji Q: Association
between IGF2BP2 rs4402960 polymorphism and risk of type 2 diabetes
mellitus: a meta-analysis. Arch Med Res. 42:361–367. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wu J, Wu J, Zhou Y, et al: Quantitative
assessment of the variation in IGF2BP2 gene and type 2 diabetes
risk. Acta Diabetol. 49(Suppl 1): S87–S97. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Toperoff G, Aran D, Kark JD, et al:
Genome-wide survey reveals predisposing diabetes type 2-related DNA
methylation variations in human peripheral blood. Hum Mol Genet.
21:371–383. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fraga MF, Ballestar E, Paz MF, et al:
Epigenetic differences arise during the lifetime of monozygotic
twins. Proc Natl Acad Sci USA. 102:10604–10609. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Barres R and Zierath JR: DNA methylation
in metabolic disorders. Am J Clin Nutr. 93:897S–900S. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Barrès R, Osler ME, Yan J, et al: Non-CpG
methylation of the PGC-1alpha promoter through DNMT3B controls
mitochondrial density. Cell Metab. 10:189–198. 2009.PubMed/NCBI
|
|
12
|
Verploegen S, Ulfman L, van Deutekom HW,
et al: Characterization of the role of CaMKI-like kinase (CKLiK) in
human granulocyte function. Blood. 106:1076–1083. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shu XO, Long J, Cai Q, et al:
Identification of new genetic risk variants for type 2 diabetes.
PLoS Genet. 6:e10011272010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Imamura M, Iwata M, Maegawa H, et al:
Genetic variants at CDC123/CAMK1D and SPRY2 are associated with
susceptibility to type 2 diabetes in the Japanese population.
Diabetologia. 54:3071–3077. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Schleinitz D, Tönjes A, Böttcher Y, et al:
Lack of significant effects of the type 2 diabetes susceptibility
loci JAZF1, CDC123/CAMK1D, NOTCH2, ADAMTS9, THADA, and TSPAN8/LGR5
on diabetes and quantitative metabolic traits. Horm Metab Res.
42:14–22. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Murea M, Lu L, Ma L, et al: Genome-wide
association scan for survival on dialysis in African-Americans with
type 2 diabetes. Am J Nephrol. 33:502–509. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dupuis J, Langenberg C, Prokopenko I, et
al: New genetic loci implicated in fasting glucose homeostasis and
their impact on type 2 diabetes risk. Nat Genet. 42:105–116. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ribel-Madsen R, Fraga MF, Jacobsen S, et
al: Genome-wide analysis of DNA methylation differences in muscle
and fat from monozygotic twins discordant for type 2 diabetes. PLoS
One. 7:e513022012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Alberti KG and Zimmet PZ: Definition,
diagnosis and classification of diabetes mellitus and its
complications. Part 1: diagnosis and classification of diabetes
mellitus provisional report of a WHO consultation. Diabet Med.
15:539–553. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
García-Giménez JL, Sanchis-Gomar F, Lippi
G, et al: Epigenetic biomarkers: A new perspective in laboratory
diagnostics. Clin Chim Acta. 413:1576–1582. 2012.PubMed/NCBI
|
|
21
|
Zampetaki A, Kiechl S, Drozdov I, et al:
Plasma microRNA profiling reveals loss of endothelial miR-126 and
other microRNAs in type 2 diabetes. Circ Res. 107:810–817. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhao C, Dong J, Jiang T, et al: Early
second-trimester serum miRNA profiling predicts gestational
diabetes mellitus. PLoS One. 6:e239252011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dehwah MA, Xu A and Huang Q: MicroRNAs and
type 2 diabetes/obesity. J Genet Genomics. 39:11–18. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Poy MN, Eliasson L, Krutzfeldt J, et al: A
pancreatic islet-specific microRNA regulates insulin secretion.
Nature. 432:226–230. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Husseiny MI, Kuroda A, Kaye AN, Nair I,
Kandeel F and Ferreri K: Development of a quantitative
methylation-specific polymerase chain reaction method for
monitoring beta cell death in type 1 diabetes. PLoS One.
7:e479422012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kong L, Zhu J, Han W, et al: Significance
of serum microRNAs in pre-diabetes and newly diagnosed type 2
diabetes: a clinical study. Acta Diabetol. 48:61–69. 2011.
View Article : Google Scholar : PubMed/NCBI
|
